Related Experiment Videos
Double-blind trial of mazindol in overweight patients
The Medical Journal of Australia
|October 4, 1975
Abstract:
A 12-week double-blind trial involving 50 patients from a suburban general practice showed a highly significant loss of weight in the group taking 2 mg of mazindol (Sanorex) per day.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cervical smear frequency pattern at an Australian screening centre.
The Medical journal of Australia·1977
The effect of progestogens on vaginal cytology.
Acta cytologica·1975
Not Gone but Often Forgotten: Action Needed to Address Tuberculosis in Aboriginal and Torres Strait Islander Communities.
The Medical journal of Australia·2026
Newborn Screening: Equity for Aboriginal and Torres Strait Islander Families in the Context of Emerging Genomics.
The Medical journal of Australia·2026
Time for an Update: The Currency of Clinical Guidelines in Australia-A Cross-Sectional Analysis.
The Medical journal of Australia·2026
Forty Years in the Making: Reporting on the Co-Creation of a National Roadmap for Birthing on Country Services for the Best Start to Life.
The Medical journal of Australia·2026
Advancements in pharmaceutical research on traditional Chinese medicine-metal complexes.
Journal of pharmaceutical analysis·2026
NMDA subunit 2B-selective negative allosteric modulator satoprodil (BI 1569912) as mono- and adjunctive therapy in patients with major depressive disorder: results from two phase 2 randomized, controlled trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Therapeutic effect of curdlan in experimental visceral leishmaniasis is mediated by activation of NLRP3 inflammasome.
Experimental parasitology·2026
Chemical profiling of Egregia menziesii and anti-inflammatory potential in LPS-activated RAW 264.7 macrophages.
Molecular biology reports·2026